Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 March 2025 | Story Precious Shamase | Photo Kwanele Madonsela
Deputy Director   - Academy for Multilingualism with the school teachers showing off the donated Dictionaries
Dr Tholani Hlongwa (middle), Deputy Director of the UFS Academy for Multilingualism, emphasised that such initiatives promote a deeper appreciation of diverse perspectives while helping to overcome communication barriers among learners.

International Mother Language Day marks its silver jubilee, highlighting 25 years of linguistic diversity advocacy. On Friday 21 February 2025, the world observed the 25th anniversary of International Mother Language Day, a milestone celebrating a quarter of a century of efforts to promote multilingualism and cultural preservation.

International Mother Language Day, observed annually, promotes awareness of linguistic and cultural diversity and multilingualism. The UFS Qwaqwa Campus' 2025 event not only celebrated this diversity, but it also provided tangible support to the local education system.

The event placed a spotlight on the importance of mother tongue-based education (MTBE), particularly as the South African government and the Department of Education continue to roll out MTBE in the fourth year of schooling (Grade 4).

The day’s primary objective was to cultivate a welcoming environment where learners could share their languages and cultural identities, a vision that directly aligns with the UFS’ Vision 130. This strategic framework champions inclusivity, which aims to create platforms where diverse communities can interact and learn from one another, solidifying a sense of belonging for all.

A key feature of the commemoration was the distribution of 40 bilingual pictorial dictionaries to two local primary schools in Qwaqwa. Notably, one school caters for hearing learners, while the other provides education for Deaf learners, ensuring inclusivity in the initiative.

"This event was more than just a celebration; it was a powerful demonstration of inclusivity in action," stated Dr Tholani Hlongwa, Deputy Director from the UFS Academy for Multilingualism. "By bringing together Deaf and hearing learners, we are breaking down communication barriers and fostering a deeper understanding of each other's unique perspectives."

"This year's commemoration held particular significance, as we witnessed the continued progression of mother tongue-based education within our national curriculum," said Dr Hlongwa. "These bilingual dictionaries will serve as invaluable tools for both teachers and learners, fostering a deeper understanding and appreciation of their mother languages."

The distribution of these resources aimed to support teaching and learning directly within the beneficiary schools, reinforcing the university's commitment to community engagement and educational development.

The Academy for Multilingualism at the UFS plays a crucial role in promoting and researching multilingualism, and this event highlighted its dedication to advancing language equity. The University of the Free State continues to demonstrate its dedication to the development of the communities surrounding its campuses.

The event at Thiboloha School for the Deaf and Blind stands as a testament to the UFS’ commitment to building a more inclusive and equitable society. By fostering dialogue and understanding, the university is actively contributing to a future where all individuals feel valued and respected. This initiative has not only enriched the lives of the participating learners, but it also set a precedent for future collaborations that champion multilingualism and inclusivity within the broader community.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept